Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Woodford-backed biotech investor also among forthcoming IPOs
Thursday 09 Feb 2017 Author: Tom Sieber

Pawnbroker Ramsdens is to float on the stock market in the coming weeks along with a trio of larger healthcare and property related companies.

The Middlesborough-headquartered business, which also sells jewellery and offers a mix of other financial services, has raised £15.6m from institutions ahead of its 15 February debut on AIM.

Key elements of the growth strategy include an expansion of the branch estate at a rate of 12 new stores a year over the medium term and boosting the company’s online footprint.

Also heading to the UK stock market is healthcare and life sciences investor Arix Bioscience. It plans to raise £100m and join the Main Market on 22 February.

Backed by noted fund manager Neil Woodford, Arix’s funds will likely be used to build on the portfolio of five biotech firms it has already invested in directly.

Impact Healthcare REIT hopes to float on 7 March. It is targeting a £160m issue to fund the acquisition of a portfolio of residential care homes. It plans to offer a dividend yield of 6%.

LXI REIT plans to raise £200m to invest in commercial properties and join the stock market in late February. The company looks set to target a yield of at least 5% a year. (TS)

‹ Previous2017-02-09Next ›